Bone marrow and stem cell transplantation: Malaysian experience

Bone Marrow Transplantation
Gg GanHm Ibrahim

Abstract

Malaysia conducted the first BMT in the country in 1987. Since then, there have been 1155 transplantations performed in a total of eight transplant centres. A majority of the transplantations were allogeneic, including myeloablative and nonmyeloablative. A vast majority of donors are HLA identical siblings. The mean age of transplanted patients was 26 years. The major reason for transplantation was hematological malignancies. The overall survival was 60% for allogeneic transplantation and 52% for autologous transplantation. The most common cause of death in transplanted patients was the underlying disease followed by infection-related complications. Currently, the government is expanding the existing public cord blood bank as well as the local donor registry.

Citations

Mar 2, 2010·Bone Marrow Transplantation·A YoshimiUNKNOWN Asia-Pacific Blood and Marrow Transplantation Group (APBMT)
Aug 15, 2009·Current Opinion in Hematology·Alois Gratwohl, Helen Baldomero
May 28, 2019·Science and Engineering Ethics·Nishakanthi GopalanMohd Salim Mohamed
May 16, 2019·Bone Marrow Transplantation·Minako IidaUNKNOWN Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.